HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeevanandam, V. Articles by Rose, E. A. Search for Related Content PubMed PubMed Citation Articles by Jeevanandam, V. Articles by Rose, E. A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 194-198, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial

V Jeevanandam, ML Barr, JS Auteri, JA Sanchez, J Fong, FA Schenkel, CC Marboe, RE Michler, CR Smith and EA Rose
Department of Surgery, Columbia-Presbyterian Medical Center, New York, NY 10032.

We have previously shown the safety and efficacy of University of Wisconsin solution for hypothermic preservation of the human donor heart in a pilot group of 16 transplant recipients. The present study is a randomized clinical trial comparing University of Wisconsin solution to conventional preservation using crystalloid cardioplegia and saline storage within a 4-hour limit of ischemia. Heart transplant recipients (n = 42) were randomized into two groups: those receiving hearts preserved by University of Wisconsin solution, the UWS group (n = 22), and those receiving hearts preserved in the conventional manner, the CCS group (n = 20). Recipient age, gender, heart disease, and preoperative inotropic support and donor age, gender, and mean ischemic time in hours (UWS 2 hours 36 minutes, range 1 hour 36 minutes to 2 hours 53 minutes; CCS 2 hours 20 minutes, range 1 hour 20 minutes to 2 hours 44 minutes; p = not significant) were similar. Significant differences observed between the two groups included (1) mean time (minutes) from reperfusion to achieve a stable rhythm, (2) need for intraoperative defibrillations, (3) need for transient cardiac pacing, and (4) integrated postoperative creatinine kinase and aspartate aminotransferase release over 48 hours. There was no difference in postoperative electrocardiogram, endomyocardial biopsy, or hemodynamics. One UWS patient died of sepsis and another of a ruptured cerebral aneurysm. UWS is safe for donor organ arrest and preservation despite high viscosity and potassium concentration. When compared with CCS hearts, hearts preserved in UWS regained electrical activity more rapidly and had better myocardial protection as demonstrated by enzymatic analysis. Further investigation is required to determine the effects of UWS preservation on long-term survival, to determine the prevalence of rejection and graft atherosclerosis, and to test the ability of UWS to extend donor ischemic time in human cardiac transplantation.

This article has been cited by other articles:

				N. Kajihara, S. Morita, Y. Tanoue, N. Boku, M. Eto, T. Nishida, and R. Tominaga The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 784 - 789. [Abstract] [Full Text] [PDF]

				F. A. Mitropoulos, J. Odim, D. Marelli, K. Karandikar, D. Gjertson, A. Ardehali, J. Kobashigawa, and H. Laks Outcome of hearts with cold ischemic time greater than 300minutes. A case-matched study Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 143 - 148. [Abstract] [Full Text] [PDF]

				Q. Yang, R.-Z. Zhang, A. P. C. Yim, and G.-W. He Effect of 11,12-epoxyeicosatrienoic acid as an additive to st. thomas' cardioplegia and university of wisconsin solutions on endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries: influence of temperature and time Ann. Thorac. Surg., November 1, 2003; 76(5): 1623 - 1630. [Abstract] [Full Text] [PDF]

				J. D. Vega, J. L. Ochsner, V. Jeevanandam, D. C. McGiffin, K. R. McCurry, R. M. Mentzer Jr, J. C. Stringham, R. N. Pierson III, O.H. Frazier, A. H. Menkis, et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts Ann. Thorac. Surg., May 1, 2001; 71(5): 1442 - 1447. [Abstract] [Full Text] [PDF]

				G. B. Luciani, G. Faggian, G. Montalbano, G. Casali, A. Forni, B. Chiominto, and A. Mazzucco BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA FOR MYOCARDIAL PROTECTION OF DONOR HEARTS DURING TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 787 - 795. [Abstract] [Full Text] [PDF]

				R. Ou, J. B. Gavin, D. S. Esmore, and F. L. Rosenfeldt Increased temperature reduces the protective effect of University of Wisconsin solution in the heart Ann. Thorac. Surg., November 1, 1999; 68(5): 1628 - 1634. [Abstract] [Full Text] [PDF]

				M. Kirsch, C. Baufreton, C. Fernandez, S. Brunet, F. Pasteau, A. Astier, and D. Y. Loisance Preconditioning with cromakalim improves long-term myocardial preservation for heart transplantation Ann. Thorac. Surg., August 1, 1998; 66(2): 417 - 424. [Abstract] [Full Text] [PDF]

				C. I. Chardigny, V. A. Jebara, T. J. Verbeuren, A. F. Carpentier, and J.-N. Fabiani Effects of cardioplegic solutions on the vasoreactivity of the internal mammary artery Ann. Thorac. Surg., August 1, 1998; 66(2): 466 - 470. [Abstract] [Full Text] [PDF]

				G.-W. He Hyperkalemia Exposure Impairs EDHF-Mediated Endothelial Function in the Human Coronary Artery Ann. Thorac. Surg., January 1, 1997; 63(1): 84 - 87. [Abstract] [Full Text]

				V. Jeevanandam, S. Furukawa, T. W. Prendergast, B. A. Todd, H. J. Eisen, and J. B. McClurken Standard Criteria for an Acceptable Donor Heart Are Restricting Heart Transplantation Ann. Thorac. Surg., November 1, 1996; 62(5): 1268 - 1275. [Abstract] [Full Text]

				Y. Tanoue, S. Morita, Y. Ochiai, M. Hisahara, M. Masuda, Y. Kawachi, R. Tominaga, and H. Yasui INHIBITION OF LIPID PEROXIDATION WITH THE LAZAROID U74500A ATTENUATES ISCHEMIA-REPERFUSION INJURY IN A CANINE ORTHOTOPIC HEART TRANSPLANTATION MODEL J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1017 - 1026. [Abstract] [Full Text]

				J. Lee, D. C. Drinkwater Jr., H. Laks, A. Chong, A. Blitz, M. A. Chen, L. J. Ignarro, and P. Chang PRESERVATION OF ENDOTHELIUM-DEPENDENT VASODILATION WITH LOW-POTASSIUM UNIVERSITY OF WISCONSIN SOLUTION J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 103 - 110. [Abstract] [Full Text]

				M. Carrier, T. K. Leung, B. C. Solymoss, R. Cartier, Y. Leclerc, and L. C. Pelletier Clinical Trial of Retrograde Warm Blood Reperfusion Versus Standard Cold Topical Irrigation of Transplanted Hearts Ann. Thorac. Surg., May 1, 1996; 61(5): 1310 - 1314. [Abstract] [Full Text]

				G.-W. He and C.-Q. Yang Hyperkalemia Alters Endothelium-Dependent Relaxation Through Non-Nitric Oxide and Noncyclooxygenase Pathway: A Mechanism for Coronary Dysfunction due to Cardioplegia Ann. Thorac. Surg., May 1, 1996; 61(5): 1394 - 1399. [Abstract] [Full Text]

				F. L. Rosenfeldt, R. A. J. Conyers, P. Jablonski, L. Langley, S. M. Richards, G. Self, and V. Marshall Comparison of UW Solution and St. Thomas' Solution in the Rat: Importance of Potassium Concentration Ann. Thorac. Surg., February 1, 1996; 61(2): 576 - 584. [Abstract] [Full Text]

				J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al. Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass Circulation, November 1, 1995; 92(9): 223 - 227. [Abstract] [Full Text]

				D. C. Drinkwater Jr., E. T. Ziv, H. Laks, J. R. Lee, S. Bhuta, E. Rudis, and P. Chang Extracellular and standard University of Wisconsin solutions provide equivalent preservation of myocardial function J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 738 - 745. [Abstract] [Full Text]

				S. E. Fremes, J. Zhang, R. D. Furukawa, D. A. G. Mickle, and R. D. Weisel ADENOSINE PRETREATMENT FOR PROLONGED CARDIAC STORAGEAn evaluation with St. Thomas' Hospital and University of Wisconsin solutions J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 293 - 301. [Abstract] [Full Text]

				G.-W. He and C.-Q. Yang Vascular Tone and Contractility During Exposure to Cardioplegia and Hyperkalemic Solutions Vascular and Endovascular Surgery, July 1, 1995; 29(4): 261 - 272. [Abstract] [PDF]

				J. C. Stringham, K. L. Paulsen, J. H. Southard, R. M. Mentzer Jr., and F. O. Belzer Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 764 - 775. [Abstract] [Full Text]

				J. M. Pearl, H. Laks, D. C. Drinkwater, T. J. Sorensen, P. Chang, A. S. Aharon, R. E. Byrns, and L. J. Ignarro Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 257 - 264. [Abstract] [Full Text]